The Institut Pasteur and Mérieux Alliance signed a letter of intent to form a long-term partnership to conduct research in the field of infectious disease. Research topics will include food safety, clinical diagnostics, and immunotherapy.
The results of the collaboration could be utilized by the various Mériux Alliance companies in products, and would become part of the Institut Pasteur's patent portfolio, according to a statement.
Mérieux Alliance consists of five public health companies: bioMérieux, Silliker, Shantha Biotechnics, Transgene, and Advanced Bioscience Laboratories.
"I am extremely pleased with this agreement with Mérieux Alliance that will contribute to improving public health worldwide," says Alice Dautry, president of the Institut Pasteur. "Together, we want to develop innovative approaches that will allow us, in the future, to win new battles against disease."
The letter follows an agreement signed April 14th between the Institut Pasteur and the Fondation Mérieux to work together on controlling infectious disease in developing countries.